Demand for Novo Nordisk's Weight Loss Pill Is Strong Out of the Gate. Is the Stock Due for a Big Rally? Novo Nordisk's weight ...

Artificial intelligence isn't performing surgery yet, but if (when?) it does, these two companies are likely to be at the ...

Micron is a major memory supplier for Apple and is likely to benefit from strong iPhone sale. The memory shortage got a lot ...

Based on Meta's guidance of 30% top-line growth for Q1, which includes a 4% foreign currency tailwind, a 28% growth rate in ...

In addition to the valuation and growth prospects, 2026 will be Nu's year because of its soaring profits. Nu's business model ...

FactSet delivers integrated financial data and analytics to institutional clients, supporting investment decisions worldwide.

It isn't unusual for manufacturing companies to have high levels of debt; after all, making products is a capital-intensive ...

Dogecoin's price oscillates with narratives often drummed up on social media or in chat rooms. The catalyst behind Dogecoin's ...

A $50 investment in XRP's earliest trade in 2013 would still be worth nearly $14,700 today. I doubt it can replicate those ...

Intuit is still guiding for double-digit growth in fiscal 2026, but at a meaningfully slower rate than last year.

Investors who are risk-averse and looking for stability, reliability, and income should definitely opt for AbbVie. It's the ...

Netflix's guidance for the year reflects a notable slowdown in its growth rate, even as its ad revenue is expected to double.